Nobell Foods

The People Building It

Nobell Foods was founded in 2016 by Magi Richani, a project engineer who left her role at Shell to pursue the challenge of creating a plant-based cheese that did not compromise on taste or texture [Fast Company, July 2021]. The company is headquartered in San Francisco, California, and operates under the brand Nobell Foods, with a recent strategic rebranding to Alpine Bio signaling an expansion of its platform [AgFunderNews] [Green Queen].

The Short Version

Nobell Foods, now operating as Alpine Bio, is a food-tech company engineering dairy proteins directly in plants to create cheese alternatives that aim to match conventional dairy on taste, texture, and price, a proposition that has secured over $100 million in venture backing from a syndicate of top-tier climate and technology investors [Bloomberg, July 2021][TechCrunch, July 2021]. The company's core differentiation lies in a patented platform that uses soybeans as bioreactors to produce casein, the key protein responsible for cheese's melt and stretch [Nobell Foods][Tracxn].

Richani, the solo founder and CEO, brings an engineering mindset from her prior industry experience [Fast Company, July 2021]. The business model is B2C, targeting mainstream consumers and foodservice buyers, funded primarily by a $75 million Series B round in mid-2021 led by Breakthrough Energy Ventures [SPEEDA Edge]. Over the next 12-18 months, the critical milestones to watch are the commercial launch of its first product, animal-free mozzarella, slated for public tastings in 2025, and the progress of its self-affirmed GRAS (Generally Recognized as Safe) certification for plant-derived casein in the US [AgFunderNews][Green Queen].

Data Accuracy: GREEN -- Core company claims and funding round details corroborated by multiple independent news sources and investor profiles.

Taxonomy Snapshot

Axis	Classification
Stage	Series B
Business Model	B2C
Industry / Vertical	Agtech
Technology Type	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	$100M+ (total disclosed ~$102,540,000)

What They Have Built

The company's core proposition is a plant-based cheese that does not ask consumers to compromise on the functional properties of dairy. Nobell Foods, now operating under the parent brand Alpine Bio, engineers soybeans to produce dairy proteins, specifically casein, within the plant itself [Nobell Foods]. The resulting product is designed to melt, stretch, and taste like conventional cheese [Fast Company, July 2021]. The company frames its mission as serving the "99% of people who are unwilling to compromise on taste and price" [Y Combinator].

The patented technology platform involves modifying soybeans to express casein proteins, which the company calls "Cheesebeans™" [GFI, 2025]. After harvesting, the proteins are extracted and purified for use in cheese formulations. The company claims the process uses 90% less water and land and generates 70% fewer emissions than conventional dairy production [Pear VC]. In 2024, the company harvested its first casein-containing soybeans [GFI, 2025]. The first consumer-facing product is an animal-free mozzarella, with public tastings slated to begin in 2025 [Breakthrough Energy Ventures Job Board, 2026].

Beyond casein for cheese, the technology platform suggests potential expansion into other high-value dairy proteins. The company has noted it can also extract and purify lactoferrin from engineered soybeans [AgFunderNews, 2026]. The recent corporate rebranding to Alpine Bio, with Nobell Foods becoming a division, signals this broader platform ambition [AgFunderNews]. Regulatory progress is a current focus, with the company pursuing self-affirmed GRAS status in the U.S. for its plant-derived casein [PUBLIC].

Data Accuracy: GREEN -- Product claims and technological approach are consistently described across company materials and multiple press reports.

Market Size and Demand

The market for plant-based dairy is driven by broad consumer demand for products that offer environmental and health benefits without sacrificing taste or price. According to a Bloomberg Intelligence report cited in July 2021, the global plant-based dairy market was projected to reach $62 billion by 2030, up from $21 billion in 2020 [Bloomberg, July 2021].

Metric	Value
Global Plant-Based Dairy Market (2020)	$21B
Global Plant-Based Dairy Market (2030 Projection)	$62B

Data Accuracy: YELLOW -- Market sizing figures are drawn from a third-party analyst report cited in contemporaneous news coverage.

Who Else Is Fighting for This

Nobell Foods, now operating as Alpine Bio, competes by aiming to produce animal-identical dairy proteins in plants, a technical approach that distinguishes it from both incumbent plant-based cheese makers and the fermentation-based precision dairy sector.

Company	Positioning	Stage / Funding	Notable Differentiator
Nobell Foods (Alpine Bio)	Engineers dairy proteins (casein) directly in soybeans.	Series B; ~$103M total raised	Patented molecular farming platform.
Perfect Day	Uses precision fermentation to produce whey and casein.	Later stage; $750M+ total funding	Commercialized B2B ingredient model.
New Culture	Produces animal-free mozzarella using precision fermentation.	Series A; $25M+ total funding	Focused exclusively on fresh mozzarella.
Climax Foods	Uses data science and machine learning for plant-based cheeses.	Series B; $25M+ total funding	AI-driven formulation platform.

Data Accuracy: YELLOW -- Competitor profiles and funding stages are confirmed via Crunchbase and company sources.

Opportunity

If Nobell Foods (now Alpine Bio) can successfully scale its plant-grown casein platform, the company is positioned to capture a significant portion of the global cheese market [Bloomberg, July 2021]. The headline opportunity is to become the foundational ingredient supplier for the next generation of mainstream, animal-free dairy products. The company holds ten U.S. patents protecting its protein expression and extraction processes [AgFunderNews, 2026] [GFI, 2025].

Data Accuracy: YELLOW -- The core opportunity thesis is built on publicly stated company goals, investor backing, and patent filings.